{"id":47244,"date":"2022-08-12T15:02:02","date_gmt":"2022-08-12T13:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-diabetes-diagnostics-market-report-2022-increasing-obesity-levels-underpin-growth-researchandmarkets-com\/"},"modified":"2022-08-12T15:02:02","modified_gmt":"2022-08-12T13:02:02","slug":"global-diabetes-diagnostics-market-report-2022-increasing-obesity-levels-underpin-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-diabetes-diagnostics-market-report-2022-increasing-obesity-levels-underpin-growth-researchandmarkets-com\/","title":{"rendered":"Global Diabetes Diagnostics Market Report 2022: Increasing Obesity Levels Underpin Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Diabetes Diagnostics – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal Diabetes Diagnostics Market to Reach $42.4 Billion by 2026<\/strong>\n<\/p>\n

\nDiabetes diagnostics systems are used to measure blood glucose levels or blood sugar levels, which indicates whether or not a person is suffering from diabetes. Demand for diabetes diagnostics devices and systems is being driven by the need for easier, economic, and efficient management of the global diabetes epidemic, improving ease-of-use and accuracy of devices, and development of non-invasive techniques to simplify regular glucose testing.\n<\/p>\n

\nThe spread of diabetes at epidemic proportions is driving the requirement for pre-diabetics testing and post-prandial glucose-level monitoring. With increasing levels of patient education on possible ways of preventing and delaying the onset of Type II diabetes, more and more pre-diabetics are expected to start testing blood glucose.\n<\/p>\n

\nAdded to this, patients undergoing tests on account of complications arising from undiagnosed conditions, such as heart attacks, are likely to spur market potential. Increasing obesity levels globally coupled with growing requirements of aging patients at both facility-based geriatric care as well as home-based managed care facilities is also expected to drive demand for various diabetes diagnostic devices and systems.\n<\/p>\n

\nAmid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$30.8 Billion in the year 2022, is projected to reach a revised size of US$42.4 Billion by 2026, growing at a CAGR of 8.1% over the analysis period.\n<\/p>\n

\nThe U.S. Market is Estimated at $11.7 Billion in 2022, While China is Forecast to Reach $5.2 Billion by 2026<\/strong>\n<\/p>\n

\nThe Diabetes Diagnostics market in the U.S. is estimated at US$11.7 Billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2026 trailing a CAGR of 9.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 7.1% respectively over the analysis period.\n<\/p>\n

\nSelect Competitors (Total 91 Featured):<\/strong>\n<\/p>\n